chevron_leftBack
As of 18 June 2026, Guangdong Lifestrong Pharmacy Co., Ltd. has a market cap of $464.98M USD, ranking #15667 globally and #4922 in China.
It ranks #1400 in the Healthcare sector, and #514 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$464.98MUSD
3.14B CNY
Enterprise Value
$442.3MUSD
2.99B CNY
Revenue (TTM)
$45.87MUSD
310.01M CNY
EBITDA (TTM)
-$1.01MUSD
-6.86M CNY
Net Income (TTM)
-$644.2KUSD
-4.35M CNY
EBITDA Margin
-2.2%
Profit Margin
-1.4%
PS Ratio
10.1
PB Ratio
4.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ou Xiantao
open_in_new
Employees
667
Founded
1951
Website
wnqzy.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.3% | 1% | 3.4% | -14% | 14% | 41% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301111
广东万年青制药股份有限公司 Class A
ISIN: CNE1000054T7
Shares Out.:
Shares Outstanding:
160.0M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
19.90 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Guangdong Lifestrong Pharmacy Co., Ltd.
Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. The company produces tablets, pills, injection, mixture, granules, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and healthcare category products. Guangdong Lifestrong Pharmacy Co., Ltd. was founded in 1951 and is headquartered in Shantou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.99B
12K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.77B
11K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
6K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
4K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.56B
3K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
3K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
164K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
118K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
77K%
|
97.4
|
|
SIX: RO
|
$323.08B
69K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.5B
62K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.99B
59K%
218.9B CHF
|
20.5
|
chevron_leftBack